Physician
Epangelia Properties, LLC
Epangelia Properties, LLC was paid $14.01M by Medicaid between Jan 2018 and Dec 2024, across 124 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 37% of everything it billed.
33Billing provider infoEPANGELIA PROPERTIES, LLC
PHOENIX, AZ 85015
PHOENIX, AZ 85015
33aNPI1780819748assigned 05/20/2009
33bProvider typeFamily Medicine Physician
28Total paid$14.01M
24GClaims385,031
24DCodes billed124
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Arizona
Rank by total paid#6 of 442
Median peer was paid$77K
This provider vs. median182×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 52,218 | $1.70M | |
| 2019 | 63,315 | $2.02M | |
| 2020 | 69,387 | $2.39M | |
| 2021 | 65,712 | $2.42M | |
| 2022 | 54,138 | $2.24M | |
| 2023 | 48,025 | $1.87M | |
| 2024incomplete | 32,236 | $1.36M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 37% | 75,467 | 56,437 | $5.13M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 40,889 | 34,702 | $2.16M |
| 99401 | 14% | 65,583 | 51,652 | $1.92M | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.6% | 4,794 | 4,596 | $501K |
| 92557 | 3.4% | 14,271 | 13,960 | $480K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 2.7% | 3,848 | 3,792 | $374K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2.6% | 4,070 | 4,012 | $367K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.3% | 3,638 | 3,141 | $317K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.6% | 11,741 | 11,348 | $222K |
| 99385 | 1.4% | 1,988 | 1,937 | $190K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.2% | 5,942 | 5,403 | $173K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.2% | 2,340 | 2,281 | $168K |
112 more codes
| 99441 | 1.2% | 3,808 | $162K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.1% | 1,924 | $159K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.1% | 4,962 | $153K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 10,164 | $134K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,276 | $113K |
| 99442 | <1% | 1,550 | $102K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,089 | $82K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 6,117 | $76K |
| 36415 | Collection of venous blood by venipuncture | <1% | 24,265 | $71K |
| 93880 | <1% | 540 | $62K | |
| 90686 | <1% | 5,734 | $52K | |
| 99205 | Prolong outpt/office vis | <1% | 406 | $50K |
| 99386 | <1% | 440 | $49K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,657 | $48K |
| 93923 | <1% | 531 | $46K | |
| 99402 | <1% | 984 | $43K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 1,127 | $42K |
| 93000 | <1% | 2,999 | $41K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 496 | $39K |
| 93925 | <1% | 276 | $36K | |
| 90674 | <1% | 1,814 | $36K | |
| 81025 | <1% | 4,794 | $34K | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 989 | $33K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 393 | $31K |
| 0012A | <1% | 515 | $20K | |
| 99000 | <1% | 11,824 | $19K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,617 | $18K |
| 0011A | <1% | 537 | $18K | |
| 99397 | <1% | 185 | $17K | |
| 99173 | <1% | 10,937 | $15K | |
| 0001A | <1% | 212 | $12K | |
| 0002A | <1% | 191 | $12K | |
| 94060 | <1% | 271 | $12K | |
| 90694 | <1% | 548 | $11K | |
| 93930 | <1% | 114 | $11K | |
| 0013A | <1% | 168 | $10K | |
| 90656 | <1% | 426 | $9K | |
| 81002 | <1% | 2,998 | $9K | |
| 0003A | <1% | 137 | $8K | |
| 99443 | <1% | 84 | $8K | |
| 94760 | <1% | 7,737 | $7K | |
| 86328 | <1% | 583 | $7K | |
| 94664 | <1% | 570 | $7K | |
| 97802 | <1% | 1,825 | $6K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 99 | $5K |
| 90653 | <1% | 122 | $5K | |
| 96160 | <1% | 1,931 | $5K | |
| 93042 | <1% | 620 | $4K | |
| 87210 | <1% | 812 | $4K | |
| 93970 | <1% | 26 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 257 | $4K |
| 76536 | <1% | 56 | $3K | |
| 83014 | <1% | 488 | $3K | |
| 0072A | <1% | 33 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,866 | $3K |
| 90662 | <1% | 235 | $3K | |
| 99383 | <1% | 26 | $2K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 27 | $2K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 318 | $2K |
| 0071A | <1% | 24 | $2K | |
| 90651 | <1% | 259 | $2K | |
| 20605 | <1% | 44 | $2K | |
| 90670 | <1% | 43 | $2K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,311 | $2K |
| 92250 | <1% | 33 | $1K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 298 | $1K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 13 | $960.36 |
| 90715 | <1% | 91 | $659.68 | |
| 99349 | <1% | 19 | $613.98 | |
| 82962 | <1% | 203 | $527.85 | |
| 0064A | <1% | 39 | $500.00 | |
| 90480 | <1% | 15 | $450.20 | |
| 0134A | <1% | 16 | $332.00 | |
| 86580 | <1% | 29 | $275.19 | |
| 99348 | <1% | 31 | $253.55 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 111 | $161.76 |
| G0008 | Administration of influenza virus vaccine | <1% | 340 | $102.56 |
| J3490 | Unclassified drugs | <1% | 474 | $94.06 |
| G0270 | Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes | <1% | 73 | $93.59 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 520 | $93.36 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 485 | $52.06 |
| 3008F | <1% | 5,323 | $41.48 | |
| 99070 | <1% | 1,634 | $30.69 | |
| 90713 | <1% | 203 | $14.24 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 450 | $6.96 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 147 | $5.24 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 60 | $3.00 |
| 3078F | 0% | 1,585 | $0.00 | |
| 1160F | 0% | 393 | $0.00 | |
| 1159F | 0% | 354 | $0.00 | |
| 90700 | 0% | 298 | $0.00 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 1,098 | $0.00 |
| 91300 | 0% | 154 | $0.00 | |
| 3077F | 0% | 173 | $0.00 | |
| 90687 | 0% | 30 | $0.00 | |
| 90649 | 0% | 21 | $0.00 | |
| 90707 | 0% | 31 | $0.00 | |
| 90734 | 0% | 41 | $0.00 | |
| 90648 | 0% | 14 | $0.00 | |
| 97803 | 0% | 18 | $0.00 | |
| 90633 | 0% | 13 | $0.00 | |
| 3074F | 0% | 2,018 | $0.00 | |
| 1125F | 0% | 61 | $0.00 | |
| 91301 | 0% | 505 | $0.00 | |
| 3075F | 0% | 184 | $0.00 | |
| 3079F | 0% | 651 | $0.00 | |
| 1170F | 0% | 391 | $0.00 | |
| 3080F | 0% | 223 | $0.00 | |
| 1126F | 0% | 88 | $0.00 | |
| 90716 | 0% | 62 | $0.00 | |
| 3044F | 0% | 14 | $0.00 | |
| 99406 | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSOM, LINDA (MEMBER)